Evidence map›Paper›PMID 28087635›Full record

ArticleDevelopment (Cambridge, England)2017

Retinoblastoma protein controls growth, survival and neuronal migration in human cerebral organoids.

Takeshi Matsui, Vanesa Nieto-Estévez, Sergii Kyrychenko, Jay W Schneider, Jenny Hsieh

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Cancers · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Genetic Modification of Brain Organoids.Frontiers in cellular neuroscience · 2019
    Article
  13. Applications of Human Brain Organoids to Clinical Problems.Developmental dynamics : an official publication of the American Association of Anatomists · 2019
    Review
  14. Opportunities for organoids as new models of aging.The Journal of cell biology · 2018
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Takeshi MatsuiDepartment of Molecular Biology and Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Vanesa Nieto-EstévezDepartment of Molecular Biology and Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Sergii KyrychenkoDepartment of Internal Medicine and Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Jay W SchneiderDepartment of Internal Medicine and Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA jenny.hsieh@utsouthwestern.edu jay.schneider@utsouthwestern.edu.
Jenny HsiehDepartment of Molecular Biology and Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA jenny.hsieh@utsouthwestern.edu jay.schneider@utsouthwestern.edu.ORCID 0000-0003-0214-0771
Southwestern Medical Center · US

Funding

Microenvironmental control of progenitors in organ dysfunction and repairU01HL100401 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI OLSON, ERIC N, SCHNEIDER, JAY W · 2009 to 2015
$8.3M
Training CoreU54HD087351 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI OLSON, ERIC N · 2015 to 2019
$7.8M
Diverse Roles of Adult Dentate Gyrus NeurogenesisR01NS081203 · NINDS · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI SCHARFMAN, HELEN E · 2013 to 2017
$1.8M
Circuitry mechanisms underlying new neuron development in adult and epileptic brainR01NS089770 · NINDS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GE, SHAOYU, HSIEH, JENNY · 2015 to 2019
$1.8M
Targeting aberrant neurogenesis to prevent epilepsy and associated cognitive declineR01NS093992 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI HSIEH, JENNY · 2016 to 2020
$1.7M
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological ContextsK02AG041815 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI HSIEH, JENNY · 2012 to 2016
$646k
Optogenetic intervention of pro-epileptic aberrant neurogenesisR21NS090926 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI GE, SHAOYU, HSIEH, JENNY · 2015 to 2016
$416k
NHLBI NIH HHS U01 HL100401NIA NIH HHS K02 AG041815NICHD NIH HHS U54 HD087351NINDS NIH HHS R01 NS081203NINDS NIH HHS R01 NS089770NINDS NIH HHS R01 NS093992NINDS NIH HHS R21 NS090926
6 · The paper itself

Abstract

The tumor suppressor retinoblastoma protein (RB) regulates S-phase cell cycle entry via E2F transcription factors. Knockout (KO) mice have shown that RB plays roles in cell migration, differentiation and apoptosis, in developing and adult brain. In addition, the RB family is required for self-renewal and survival of human embryonic stem cells (hESCs). Since little is known about the role of RB in human brain development, we investigated its function in cerebral organoids differentiated from gene-edited hESCs lacking RB. We show that RB is abundantly expressed in neural stem and progenitor cells in organoids at 15 and 28 days of culture. RB loss promoted S-phase entry in DCX

Indexed as

Cell MovementCell DeathCell LineCell ProliferationCell SurvivalCerebrumDoublecortin ProteinEmbryonic Stem CellsGene DeletionGene Knockout TechniquesHumansNeural Stem CellsNeuronsOrganoidsReelin ProteinRetinoblastoma ProteinDcx protein, mouseDoublecortin ProteinReelin ProteinRELN protein, humanReln protein, mouseRetinoblastoma ProteinBrainCell cycleCRISPR/Cas9Human embryonic stem cellsOrganoidRetinoblastoma

Identifiers

PMID28087635
PMCPMC5358115
OpenAlexW2952345616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.